Bio-Techne Corp (TECH)
Inventory turnover
Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost of revenue (ttm) | US$ in thousands | 429,363 | 412,434 | 408,991 | 401,857 | 387,160 | 382,560 | 376,362 | 368,572 | 366,888 | 358,143 | 355,077 | 352,441 | 349,103 | 344,308 | 330,668 | 318,436 | 298,182 | 277,619 | 266,958 | 257,136 |
Inventory | US$ in thousands | 189,446 | 191,083 | 188,373 | 185,041 | 179,731 | 179,496 | 180,839 | 186,080 | 171,638 | 169,464 | 160,233 | 150,009 | 141,123 | 128,283 | 121,858 | 117,366 | 116,748 | 109,990 | 106,590 | 106,003 |
Inventory turnover | 2.27 | 2.16 | 2.17 | 2.17 | 2.15 | 2.13 | 2.08 | 1.98 | 2.14 | 2.11 | 2.22 | 2.35 | 2.47 | 2.68 | 2.71 | 2.71 | 2.55 | 2.52 | 2.50 | 2.43 |
June 30, 2025 calculation
Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $429,363K ÷ $189,446K
= 2.27
The inventory turnover ratio of Bio-Techne Corp demonstrates notable variations over the analyzed period, reflecting shifts in inventory management efficiency and sales performance. Starting from a ratio of 2.43 as of September 30, 2020, there was a gradual upward trend reaching a peak of 2.71 by September 30, 2021, and December 31, 2021, indicating an improved ability to sell and replenish inventory within this timeframe.
However, subsequent periods reveal a declining trend. By March 31, 2022, the ratio decreased to 2.68, and the decline continued sharply through to September 30, 2022, hitting 2.35. This declining trend persisted into the first half of 2023, with ratios of 2.22 on December 31, 2022, and 2.11 on March 31, 2023. The ratio saw a slight recovery thereafter, reaching 2.15 by June 30, 2024, and maintaining a narrow range around 2.17 in subsequent quarters up until December 2024.
In the most recent period, from March 31, 2025, to June 30, 2025, the ratio increased to 2.27, hinting at marginal improvement in inventory turnover efficiency. Overall, the data indicates that Bio-Techne Corp experienced a period of increasing inventory turnover efficiency during early 2021, followed by a steady decline through late 2022 and into 2023, with some stabilization and minor recovery observed in 2024 and mid-2025. This pattern suggests potential challenges in inventory management or changes in sales cycle dynamics over the timeframe analyzed.
Peer comparison
Jun 30, 2025
Jun 30, 2025